Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to ...
ENDPOINTS NEWS23m
No­vo ex­pands pact with Flag­ship's Va­lo to in­clude obe­si­ty, di­a­betes for $190M near-term
Novo Nordisk is doubling down on its computational biotech partner Valo Health, expanding their collaboration from 11 ...